VBI Vaccines Inc (TSE:VBV) Director Jeffrey Royston Baxter acquired 4,609 shares of the stock in a transaction dated Tuesday, December 12th. The stock was acquired at an average price of C$3.88 per share, for a total transaction of C$17,882.92.
Jeffrey Royston Baxter also recently made the following trade(s):
- On Tuesday, November 28th, Jeffrey Royston Baxter acquired 15,000 shares of VBI Vaccines stock. The stock was acquired at an average price of C$4.75 per share, for a total transaction of C$71,250.00.
Shares of VBI Vaccines Inc (TSE VBV) traded down C$0.08 during trading on Friday, hitting C$5.72. The stock had a trading volume of 5,434 shares, compared to its average volume of 5,462. VBI Vaccines Inc has a fifty-two week low of C$3.85 and a fifty-two week high of C$8.94. The stock has a market capitalization of $288.82, a P/E ratio of -6.29 and a beta of 1.84.
VBI Vaccines Inc, a commercial stage biopharmaceutical company, develops vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. It is developing eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccine technology, a vaccine formulation technology that enables the thermostabilization of vaccines through a proprietary formulation and freeze-drying process.
Receive News & Ratings for VBI Vaccines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VBI Vaccines and related companies with MarketBeat.com's FREE daily email newsletter.